Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Pharmaceutics

• Publication date

  2015-03-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/mp500601zPMID 25748228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Personalized therapy for breast cancer

  2014cited by this paper
• (18)F-glyco-RGD peptides for PET imaging of integrin expression: efficient radiosynthesis by click chemistry and modulation of biodistribution by glycosylation.

  2014cited by this paper
• nab-Paclitaxel for the treatment of aggressive metastatic breast cancer.

  2014cited by this paper
• PET imaging of oestrogen receptors in patients with breast cancer.

  2013cited by this paper
• An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases.

  2013cited by this paper
• Manipulating Y receptor subtype activation of short neuropeptide Y analogs by introducing carbaboranes.

  2013cited by this paper
• Towards improved receptor targeting: anterograde transport, internalization and postendocytic trafficking of neuropeptide Y receptors

  2013cited by this paper
• Synthesis and evaluation of a (18)F-labeled diarylpyrazole glycoconjugate for the imaging of NTS1-positive tumors.

  2013cited by this paper
• Peptides and peptide conjugates: therapeutics on the upward path.

  2012cited by this paper
• Personalized Therapy in Breast Cancer

  2012cited by this paper
• Incorporation of ortho-carbaboranyl-Nε-modified L-lysine into neuropeptide Y receptor Y1- and Y2-selective analogues.

  2011cited by this paper
• Synthesis, characterization, and monkey positron emission tomography (PET) studies of [18F]Y1-973, a PET tracer for the neuropeptide Y Y1 receptor

  2011cited by this paper
• Bombesin receptor-mediated imaging and cytotoxicity: review and current status.

  2011cited by this paper
• Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38)

  2011cited by this paper
• Labeling and glycosylation of peptides using click chemistry: a general approach to (18)F-glycopeptides as effective imaging probes for positron emission tomography.

  2010cited by this paper
• Breast-cancer diagnosis by neuropeptide Y analogues: from synthesis to clinical application.

  2010cited by this paper
• Kinetic Study of Neuropeptide Y (NPY) Proteolysis in Blood and Identification of NPY3–35

  2009cited by this paper
• Molecular imaging targeting peptide receptors.

  2009cited by this paper
• The structure and function of G-protein-coupled receptors

  2009cited by this paper
• Effects of glycosylation on the stability of protein pharmaceuticals.

  2009cited by this paper
• A series of 2-O-trifluoromethylsulfonyl-D-mannopyranosides as precursors for concomitant 18F-labeling and glycosylation by click chemistry.

  2009cited by this paper
• Novel chemically modified analogues of neuropeptide Y for tumor targeting.

  2008cited by this paper
• Molecular recognition of the NPY hormone family by their receptors.

  2008cited by this paper
• Agonist induced receptor internalization of neuropeptide Y receptor subtypes depends on third intracellular loop and C-terminus.

  2008cited by this paper
• Guanidine-acylguanidine bioisosteric approach in the design of radioligands: synthesis of a tritium-labeled N(G)-propionylargininamide ([3H]-UR-MK114) as a highly potent and selective neuropeptide Y Y1 receptor antagonist.

  2008cited by this paper
• Receptor Subtype-specific Docking of Asp6.59 with C-terminal Arginine Residues in Y Receptor Ligands*

  2007cited by this paper
• NPY receptors in human cancer: a review of current knowledge.

  2007cited by this paper
• Molecular targeting with peptides or peptide-polymer conjugates: just a question of size?

  2005cited by this paper
• Candidates for peptide receptor radiotherapy today and in the future.

  2005cited by this paper
• The GRAFS classification system of G-protein coupled receptors in comparative perspective.

  2005cited by this paper
• Peptide receptors as molecular targets for cancer diagnosis and therapy.

  2003cited by this paper
• Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting

  2002cited by this paper
• Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets.

  2001cited by this paper
• Is Galpha16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors?

  2001cited by this paper
• Peptides as carrier for tumor diagnosis and treatment.

  2001cited by this paper
• Is Gα16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors?

  2001cited by this paper
• Novel analogues of neuropeptide Y with a preference for the Y1-receptor.

  2001cited by this paper
• Molecular characterization of the ligand–receptor interaction of the neuropeptide Y family

  2000cited by this paper
• XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors.

  1998cited by this paper
• Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide.

  1996cited by this paper
• Cloning of a Human Receptor of the NPY Receptor Family with High Affinity for Pancreatic Polypeptide and Peptide YY (*)

  1995cited by this paper
• Characterization of high‐affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC‐3 and DU‐145: Internalization of receptor bound 125I‐(Tyr4) bombesin by tumor cells

  1994cited by this paper
• Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations.

  1994cited by this paper
• Peptide Stability in Drug Development. II. Effect of Single Amino Acid Substitution and Glycosylation on Peptide Reactivity in Human Serum

  1993cited by this paper
• Cloned human neuropeptide Y receptor couples to two different second messenger systems.

  1992cited by this paper
• [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist.

  1990cited by this paper
• Highly potent and small neuropeptide Y agonist obtained by linking NPY 1-4 via spacer to alpha-helical NPY 25-36.

  1989cited by this paper
• Highly potent and small neuropeptide Y agonist obtained by linking NPY 1–4 via spacer to α‐helical NPY 25–36

  1989cited by this paper
• Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide

  1982cited by this paper

• Truncated NPY-based NPY(Y1)R-specific radiopeptides: Improved in vivo PET tumor imaging by application of peptidase inhibitors

  2024cites this paper
• Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic.

  2024cites this paper
• Engineering peptide drug therapeutics through chemical conjugation and implication in clinics

  2024cites this paper
• Development of Radiopharmaceuticals for NPY Receptor-5 (Y5) Nuclear Imaging in Tumors by Synthesis of Specific Agonists and Investigation of Their Binding Mode.

  2023cites this paper
• Radiochemistry for positron emission tomography

  2023cites this paper
• Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling

  2023cites this paper
• Nanostructured multifunctional stimuli-responsive glycopolypeptide-based copolymers for biomedical applications.

  2023cites this paper
• Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies

  2023cites this paper
• NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer

  2022cites this paper
• Neurotransmitters: Potential Targets in Glioblastoma

  2022cites this paper
• PET Imaging of the Neuropeptide Y System: A Systematic Review

  2022cites this paper
• Expression of hypoxia inducible factor–dependent neuropeptide Y receptors Y1 and Y5 sensitizes hypoxic cells to NPY stimulation

  2022cites this paper
• HIF-dependent Neuropeptide Y Receptor Y1 and Y5 expression sensitizes hypoxic cells to NPY stimulation

  2021cites this paper
• Sweetening Pharmaceutical Radiochemistry by 18F-Fluoroglycosylation: Recent Progress and Future Prospects

  2021cites this paper
• Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies

  2020cites this paper
• Design, synthesis, and biological evaluation of a multifunctional neuropeptide-Y conjugate for selective nuclear delivery of radiolanthanides

  2020cites this paper
• Targeting of peptide‐binding receptors on cancer cells with peptide‐drug conjugates

  2020cites this paper
• Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer

  2019cites this paper
• Synthesis of a tubugi-1-toxin conjugate by a modulizable disulfide linker system with a neuropeptide Y analogue showing selectivity for hY1R-overexpressing tumor cells

  2019cites this paper
• HBED-NN: A Bifunctional Chelator for Constructing Radiopharmaceuticals.

  2019cites this paper
• 18F-labelled triazolyl-linked argininamides targeting the neuropeptide Y Y1R for PET imaging of mammary carcinoma

  2019cites this paper
• A Y1 receptor ligand synergized with a P-glycoprotein inhibitor improves the therapeutic efficacy of multidrug resistant breast cancer.

  2019cites this paper
• Selective neuropeptide Y conjugates with maximized carborane loading as promising boron delivery agents for boron neutron capture therapy.

  2019cites this paper
• Efficient cartridge purification for producing high molar activity [18F]fluoro-glycoconjugates via oxime formation.

  2018cites this paper
• Y1 receptor ligand-based nanomicelle as a novel nanoprobe for glioma-targeted imaging and therapy.

  2018cites this paper
• pH protective Y1 receptor ligand functionalized antiphagocytosis BPLP-WPU micelles for enhanced tumor imaging and therapy with prolonged survival time.

  2018cites this paper
• Research progresses on the functional polypeptides in the detection and imaging of breast cancer.

  2018cites this paper
• Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics

  2018cites this paper
• PRETARGETED PET IMAGING OF POROUS SILICON NANOPARTICLES AND MONOCLONAL ANTIBODIES : DEVELOPMENT OF 18F-FLUOROGLYCOSYLATED TETRAZINE TRACER FOR THE IEDDA REACTION IN VIVO

  2018cites this paper
• Prototypic 18F-Labeled Argininamide-Type Neuropeptide Y Y1R Antagonists as Tracers for PET Imaging of Mammary Carcinoma.

  2017cites this paper
• Neuropeptide Y Y1 receptor-mediated biodegradable photoluminescent nanobubbles as ultrasound contrast agents for targeted breast cancer imaging.

  2017cites this paper
• Targeting the Neuropeptide Y1 Receptor for Cancer Imaging by Positron Emission Tomography Using Novel Truncated Peptides.

  2016cites this paper
• Click Chemistry and Radiochemistry: The First 10 Years.

  2016cites this paper
• On-resin Diels-Alder reaction with inverse electron demand: an efficient ligation method for complex peptides with a varying spacer to optimize cell adhesion.

  2016cites this paper
• Recent developments in radiolabelled peptides for PET imaging of cancer

  2016cites this paper
• Neuropeptide Y receptors: a promising target for cancer imaging and therapy

  2015cites this paper
• International Journal of Molecular Sciences Review: Receptor Targeted Nuclear Imaging of Breast Cancer

  year unknowncites this paper